Clinical trials
Ovarian Neoplasms trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
257 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2005 | 5 |
| 2006 | 5 |
| 2007 | 2 |
| 2008 | 7 |
| 2009 | 8 |
| 2010 | 11 |
| 2011 | 6 |
| 2012 | 7 |
| 2013 | 11 |
| 2014 | 11 |
| 2015 | 9 |
| 2016 | 13 |
| 2017 | 13 |
| 2018 | 14 |
| 2019 | 14 |
| 2020 | 15 |
| 2021 | 20 |
| 2022 | 15 |
| 2023 | 13 |
| 2024 | 21 |
| 2025 | 18 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 123 |
| Recruiting | 60 |
| Active, not recruiting | 33 |
| Terminated | 27 |
| Unknown status | 10 |
| Withdrawn | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 25 |
| AbbVie | 11 |
| Hoffmann-La Roche | 11 |
| Eli Lilly and Company | 9 |
| Novartis Pharmaceuticals | 9 |
| European Organisation for Research and Treatment of Cancer - EORTC | 8 |
| Merck Sharp & Dohme LLC | 6 |
| Tesaro, Inc. | 6 |
| Grupo Español de Investigación en Cáncer de Ovario | 5 |
| Amgen | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 257 |
| Fallopian Tube Neoplasms | 56 |
| Endometrial Neoplasms | 51 |
| Carcinoma, Non-Small-Cell Lung | 49 |
| Breast Neoplasms | 37 |
| Triple Negative Breast Neoplasms | 32 |
| Neoplasms | 29 |
| Uterine Cervical Neoplasms | 29 |
| Colorectal Neoplasms | 28 |
| Stomach Neoplasms | 27 |
Trials
Showing 26 to 50 of 257. Each trial links to its page on Pharma Observatory.
157 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.